Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowMAX Power Announces Strategic $25 Million Investment by Eric Sprott to Accelerate Commercial Advancement of Canada’s First-Ever Subsurface Natural Hydrogen System
Just nowDLP Resources Announces Closing of Brokered Offering for Gross Proceeds of C$6 Million
Just nowData Storage Corporation Announces Expiration of Public Warrants (NASDAQ: DTSTW)
1m agoMIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
1m agoParatus Energy: Invitation to Q1 2026 Earnings Call
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

About

4.28USD-0.05 -1.15%
Closed • Updated at 13:13 GMT+00:00
Market Cap$175.16M
P/E Ratio1.66
Volume149.3K
Beta0.98
RSI55.49
Health TechnologyPharmaceuticals: Major

Oramed Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 25 2026
Lifeward Successfully Closes on Strategic Partnership with Oramed
Jan 13 2026
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
Jan 13 2026
Oramed and Lifeward Announce Strategic Transaction
Jan 7 2026
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Nov 17 2025
Oramed Reports Fiscal Third Quarter 2025 Financial Results

Community Chat

Ask AI

6ix6ixAIEvents